Stocktoria
CHINA PHARMA HOLDINGS, INC. CPHI
NYSE American · XASE · stock · Pharmaceutical Preparations · website · IPO 2000-02-15
CHINA PHARMA HOLDINGS, INC. statistics & valuation
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -3.2% | -43.8% | -4.0% | -6.1% | 3.6% | 18.0% | 13.6% | 16.0% | 18.7% | 20.7% |
| Operating margin | -78.2% | -101.3% | -39.2% | -43.8% | -29.7% | -23.7% | -186.8% | -84.7% | -141.4% | -52.4% |
| Net margin | -76.9% | -104.6% | -43.9% | -49.0% | -35.3% | -26.4% | -189.5% | -87.2% | -145.9% | -59.0% |
| FCF margin | 2.1% | -9.8% | -10.1% | -10.0% | -7.1% | -8.4% | 4.3% | 14.8% | 5.3% | 17.4% |
| Return on assets | -10.3% | -31.8% | -18.7% | -22.3% | -15.0% | -13.6% | -93.1% | -23.7% | -32.2% | -11.7% |
| Return on equity | -14.0% | -61.1% | -41.3% | -92.6% | -56.5% | -35.8% | -224.1% | -35.6% | -44.8% | -15.6% |
| Debt / equity | — | — | — | — | — | 0.65× | 0.47× | 0.22× | 0.21× | — |
| Current ratio | 0.32 | 0.65 | 0.88 | 0.47 | 0.86 | 0.47 | 0.56 | 0.87 | 1.33 | 1.68 |
Source: SEC EDGAR filings · CIK 0001106644 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.